- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04906824
Post-Market Registry in Europe and US for the Use of VascuCelTM (VascuCel)
Study Overview
Status
Intervention / Treatment
Detailed Description
Post-market, prospective, multi-centre, open-label, registry designed to collect prospective safety and performance data on the use of VascuCel in patients with vascular disorders and in accordance with local standard of care. The Registry has been designed to collect data up to 2 years following implantation. The VascuCel Registry will collect data on the use of the VascuCel, for the following major indications:
- Great vessel reconstruction
- Peripheral vascular reconstruction
As suture line buttressing is a procedure that does not consistently use tissue, data on this indication will only be included if available. Data will be prospectively collected by the sites on registry-specific electronic case report forms (eCRFs). The primary endpoints will assess device's safety and performance through measures and images obtained via the facility's standard of care at the respective registry site. Additional data will also be collected from the implant procedure to assess user (surgeon) satisfaction with the devices' handling and performance.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ioana Ghiu
- Phone Number: 001 612 219 6032
- Email: ighiu@anteristech.com
Study Contact Backup
- Name: Marit Balder
- Phone Number: 1162 +31 30 229 2727
- Email: marit.balder@avaniaclinical.com
Study Locations
-
-
-
Varese, Italy, 21100
- Not yet recruiting
- ASST Sette Laghi Varese
-
Contact:
- Gabriele Piffaretti, Prof
- Email: gabriele.piffaretti@uninsubria.it
-
-
-
-
Idaho
-
Coeur d'Alene, Idaho, United States, 83814
- Recruiting
- Kootenai Health
-
Contact:
- Elizabeth Brewer
- Email: EBrewer@kh.org
-
-
Nevada
-
Las Vegas, Nevada, United States, 27599
- Not yet recruiting
- Eddy Luh
-
Contact:
- Eddy Luh
- Email: drluh@lvsurgical.com
-
-
New York
-
Valhalla, New York, United States, 10595
- Not yet recruiting
- Westchester Medical Center
-
Contact:
- Romeo Mateo, MD
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Recruiting
- University North Carolina
-
Contact:
- Eric Cannon
- Email: OSPContracting@unc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- patient has signed the informed consent
- patient is a candidate for treatment with VascuCel per approved device indications.
Exclusion Criteria:
- no study specific exclusion criteria; patients treated per standard clinical practice
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of graft related reintervention
Time Frame: 30 days post procedure.
|
collect data on the number of incidence of graft related reintervention
|
30 days post procedure.
|
Incidence of patch related morbidity
Time Frame: 30 days post procedure.
|
collect data on patch related morbidity
|
30 days post procedure.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of graft related reintervention
Time Frame: at 1 and 2 years post procedure.
|
collect data on the number of graft related reintervention
|
at 1 and 2 years post procedure.
|
Rates of restenosis
Time Frame: at 30 days and 1 and 2 years follow-up
|
collect rate of restenosis
|
at 30 days and 1 and 2 years follow-up
|
Rates of measurement of the dynamic flow by facility standard of care ≥110-175* cm/sec for peripheral vascular location
Time Frame: at 30 days and 1 and 2 years follow-up
|
collect rate of measurement of the dynamic flow
|
at 30 days and 1 and 2 years follow-up
|
incidence of Patch dehiscence
Time Frame: at 30 days and 1 and 2 years follow-up
|
collect rate of patch dehiscence
|
at 30 days and 1 and 2 years follow-up
|
incidence of Patch calcification
Time Frame: at 30 days and 1 and 2 years follow-up
|
collect rate of patch calcification
|
at 30 days and 1 and 2 years follow-up
|
incidence of Patch retraction
Time Frame: at 30 days and 1 and 2 years follow-up
|
collect rate of patch retraction
|
at 30 days and 1 and 2 years follow-up
|
incidence of unanticipated and rare events
Time Frame: at 30 days and 1 and 2 years follow-up
|
collect rate of unanticipated and rare events
|
at 30 days and 1 and 2 years follow-up
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- GLRA-G011
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Great Vessel Reconstruction
-
GLYCAR SA (Pty) LtdRecruitingCongenital Premature Cardiac Closure | Cardiac and Great Vessel Reconstruction and Repair | Peripheral Vascular Reconstruction and RepairFrance
-
LeMaitre VascularFactory CRO for Medical Devices B.V.RecruitingIntracardiac and Septal Defects | Valve and Anulus Repair | Great Vessel Reconstruction | Peripheral Vessel Reconstruction | Suture Line ButtressingGermany, Italy, Spain, United Kingdom
-
Xin Jiang, MDUnknownGreat Auricular NerveChina
-
The Hospital for Sick ChildrenRecruitingTGA - Transposition of Great ArteriesCanada
-
Englewood Hospital and Medical CenterCompletedGreat Saphenous Vein InsufficiencyUnited States
-
Mentor Worldwide, LLCActive, not recruitingBreast Reconstruction, Revision Breast ReconstructionUnited States
-
GC AestheticsNot yet recruitingBreast Augmentation | Breast Reconstruction | Breast Reconstruction Following Mastectomy | Breast Reconstruction Surgery | Breast Implants | Breast Revision | Breast Reconstruction With Silicone Implants | Breast Reconstruction After Mastectomy
-
Medical University of ViennaRecruitingEndovenous Laser Ablation | Great Saphenous Vein IncompetenceAustria
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationActive, not recruitingBreast Reconstruction | Implant-Based Breast Reconstruction (IBBR)Austria, Sweden, Germany, Hungary, Switzerland, United States, Italy
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Imagine InstituteRecruiting
Clinical Trials on great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing
-
LeMaitre VascularActive, not recruiting